AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Metffil G1 Tablet

Prescription Icon
Prescription Required

Marketer

Fourrts India Laboratories Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metffil G1 Tablet

GlucoDuo tablets are a dual-action antidiabetic medication used in adult patients with type 2 diabetes. This formulation combines two active ingredients to effectively manage blood glucose levels. Always take GlucoDuo with food, consistently at the same time daily for optimal results. Dosage will be determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar; abrupt cessation without medical supervision can lead to dangerously elevated glucose, potentially causing kidney complications, vision impairment, nerve damage, and limb loss. Remember, GlucoDuo is one component of a comprehensive diabetes management plan that also includes a doctor-recommended diet, exercise, and weight management. Lifestyle choices are key to successful diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and know how to treat it promptly. Consistent meals and carrying a fast-acting glucose source (like sugary snacks or juice) are essential precautions. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Patients with a history of heart disease should inform their doctor before starting GlucoDuo. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, will be recommended by your doctor.

Uses of Metffil G1 Tablet

Managing type 2 diabetes

Major Benefits of Metffil G1 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metffil G1 Tablets should be administered with a meal.

Common Side effects of Metffil G1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metffil G1 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Metffil G1 Tablet with a meal.

How Metffil G1 Tablet works:

Metformin and Glimepiride, combined as Metffil G1 Tablet, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing liver glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Metffil G1 Tablet and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Metffil G1 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Metffil G1 Tablet are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Individuals with kidney impairment should use Metffil G1 Tablets cautiously, potentially requiring dosage modification. Medical advice is essential. Metffil G1 Tablets are contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metffil G1 Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A low initial dose is typically prescribed for those with mild to moderate liver disease; Metffil G1 Tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metffil G1 Tablet :

Should you forget a Metffil G1 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Metffil G1 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Metffil G1 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Metffil G1 Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). While rare, this harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention, including discontinuing Metffil G1, if these symptoms appear.
Metffil G1 Tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Metffil G1 Tablet may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Yes, prolonged Metffil G1 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metffil G1 Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metffil G1 Tablet and alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Metffil G1 Tablet
42
MRP 51
17% off